ECOG PCO-RL: Phase III Study of Adriamycin/Taxotere vs. Adriamycin/Cytoxan for the Adjuvant Treatment of Node Positive or High Risk Node Negative Breast Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date12/10/0412/31/19

Funding

  • Frontier Science and Technology Research Foundation (PCOE2197 E2197)
  • Aventis S.A. (PCOE2197 E2197)